{
    "2021-11-10": [
        [
            {
                "time": "",
                "original_text": "华大基因：上半年，公司海外业务收入占比超60%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "海外业务",
                        "收入占比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：目前，公司合成类业务主要包含基因合成、Oligo合成等",
                "features": {
                    "keywords": [
                        "华大基因",
                        "合成类业务",
                        "基因合成",
                        "Oligo合成"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "基因工程"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：公司暂未参加一氧化碳合成蛋白质的相关项目",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一氧化碳合成",
                        "蛋白质",
                        "相关项目"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "新材料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“宏基因组”研究，中美两国进行得如何了？",
                "features": {
                    "keywords": [
                        "宏基因组",
                        "中美研究"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "国际合作"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}